Currently-used mechanical and biological heart valve prostheses have a satisfactory short-term performance, but may exhibit several major drawbacks on the long-term. Mechanical prostheses, based on carbon, metallic and polymeric components, require permanent anticoagulation treatment, and their usage often leads to adverse reactions, e.g. thromboembolic complications and endocarditis. In recent years, there is a need for a heart valve prosthesis that can grow, repair and remodel. The concept of tissue engineering offers good prospects into the development of such a device. An ideal scaffold should mimic the structural and purposeful profile of materials found in the natural extracellular matrix (ECM) architecture. The goal of this study was to develop cellulose acetate scaffolds (CA) for valve tissue regeneration. After their thorough physicochemical and biological characterization, a biofunctionalization process was made to increase the cell proliferation. Especially, the surface of scaffolds was amplified with functional molecules, such as RGD peptides (Arg-Gly-Asp) and YIGSRG laminins (Tyrosine-Isoleucine-Glycine-Serine-Arginine-Glycine) which immobilized through biotin-streptavidin bond, the strongest non-covalent bond in nature. Last step was to successfully coat an aortic metallic valve with CA biofunctionallized nanoscaffolds and cultivate cells in order to create an anatomical structure comparable to the native valve. Promising results have been obtained with CA-based nanoscaffolds. We found that cells grown successfully on the biofunctionalized valve surface thereby scaffolds that resemble the native tissues, elaborated with bioactive factors such as RGD peptides and laminins not only make the valve's surface biocompatible but also they could promote endothyliazation of cardiac valves causing an anti-coagulant effect.
Introduction
Cardiovascular disease (CVD) represents a major worldwide health care issue. A considerable amount of the disease is represented by heart valve failures. The number of patients requiring heart valve replacement is estimated to triple from approximately 290,000 in 2003 to over 850,000 by 2050 [1] [2] [3] . The heart valve industry in the US is vibrant and healthy, enjoying a growth in the market of 5% per year, selling roughly 300,000 valves worldwide [4] . As a result, the economic costs for the treatment and care of patients are estimated at several billion dollars [5] . Thus scientists try hard to develop a new type of heart valve that can potentially revolutionize the industry [6] and improve patient's lives. However, the current substitute heart valves have proven to be clinically successful over the short-term, but show several poignant long-term disadvantages [7] [8] . In particular, the tissue valves including bioprosthetic valves [porcine aortic valve or bovine pericardial xenograft], cadaveric allograft, or pulmonaryto-aortic autograft valves [9] , are effective for a specific period and require replacement again.
Additionally, xenogenous and allogenous biological heart valve prostheses evoke an immune reaction of the patient's organism, thrombosis and undergo degeneration, calcification and structural deterioration [10] [11] [12] . On the other hand, although the mechanical prostheses (mainly made of pyrolytic carbon combined with metallic and polymeric components) [1] are durable and for whole lifetime of the patient, they carry risks associated either with the valve itself, e.g. thrombus formation, thromboembolic complications, endocarditis that occurs predominantly on the surface of foreign materials, or risks related to permanent and long-lasting anticoagulation therapy, e.g. bleeding complications occurring at 1% patients per year [13] . Therefore, an alternative way to improve the quality of heart valve prostheses is to combine the present knowledge and construct bioartificial valves by tissue engineering. A tissue-engineered valve promises to be a living implant with a potential to grow and lasts a lifetime, like most native valves do [6] . Therefore, efforts are made to prepare bioartificial heart valves with an autologous biological component by tissue engineering [1] . The ideal valve prosthesis should be easily implantable, should develop a physiological hemodynamic performance without structural deterioration, and should be non-thrombogenic, nonimunogenic and silent in its performance [14] . For this purpose, scaffolds composed of synthetic materials, such as poly (lactic acid), poly (caprolactone), poly (4-hydroxybutyrate), hydrogels or natural polymers, e.g. collagen, elastin, fibrin or hyaluronic acid, have been seeded with autologous differentiated, progenitor or stem cells [1] . In recent years, a very promising natural polymer in the field of tissue engineering is cellulose acetate (CA). Cellulose acetate is derived from cellulose with chemical conversion [15] , which is the most abundant, renewable, naturally occurring polysaccharide formed out of glucose-based repeat units, connected by 1,4-beta-glucosidic linkages [16] . It can be easily fabricated into nanofibrous structures by using the electrospinning method [17] . Electrospinning is a versatile and well-established technique broadly applied for the fabrication of nanofibrous meshes as scaffolds for tissue engineering applications. With recent developments in electrospinning, both synthetic and natural polymers can be produced as nanofibers with diameters ranging from tens to hundreds of nanometers with controlled morphology and function. Electrospun scaffolds exhibit a preferential and easy to modulate morphology due to their unique geometrical features which replicate many in vivo structures. The potential of these electrospun nanofibers in human healthcare applications is promising, for example in tissue/organ repair and regeneration, as vectors to deliver drugs and therapeutics, as biocompatible and biodegradable medical implant devices, in medical diagnostics and instrumentation, as protective fabrics against environmental and infectious agents in hospitals and general surroundings, and in cosmetic and dental applications [18] [19] [20] [21] . Moreover, electrospinning parameters such as, solvent composition, polymer concentration and flow rate, impact the structure of CA scaffolds. Solvent selection along with flow rate strongly influenced the cellulose acetate fiber size, size distribution, and fiber geometry [22] [23] . Electrospun CA nanofibers have found miscellaneous applications such as in immobilization of bioactive substances, cell culture, tissue engineering, and optical device/biosensor application [24] . Cellulose acetate scaffolds and regenerated cellulose scaffolds promote cardiac cell growth; enhance cell connectivity and electrical functionality. Also, biodegradability can be controlled by hydrolysis, de-acetylization of CA and cytocompatibility enzyme action, with glucose as a final product [16] . Additionally, the CA-based nanofibrous scaffolds improve their integrity by blending with other polymers like PBA [poly(butyl acrylate)] [25] . In vitro growth of cardiac cells and tissuelike cardiac constructs for physiomics type of research could benefit from the versatility and accessibility of cellulose scaffolds; their use for tissue regeneration should also be considered [16] . Polymeric and metallic materials are used extensively in permanently implanted cardiovascular devices and devices that make temporary but often prolonged contact with body fluids and tissues. A recent study examines the evolving plasma treatment technology facilitating the biofunctionalization of polymeric and metallic implantable cardiovascular materials [26] . Moreover, surface modification of RGD peptides onto acellularized porcine aortic valve helps to promote cell adhesion [27] .
Previous biomedical applications of cellulose-derived materials suggest their potential use as general supporting and guiding structures for cell culture and possibly for reparative tissue engineering [16] . The aim of the present study was to develop and characterize CA-based scaffolds as coating in aortic heart valves. The ultimate goal was to create a biomimetic nanofibrous environment which simulates the extracellular matrix (ECM) of native cardiac tissues and thus promotes cell adhesion and proliferation in order to avoid heart valve thrombosis. Producing nanοfibrous scaffolds of biodegradable polymer CA was accomplished by the Electrospray Deposition method. Electrospun CA nanofibers were physiochemical, structural and morphological characterized. The Atomic Force Microscopy (AFM) was applied to study the surface nanotopography of the scaffolds and the Scanning Electron Microscopy (SEM) was used in order to study the topography and morphology of the scaffolds. Concomitantly, we studied wettability of the samples with contact angle measurements and degradation rates of the CA scaffolds in a 2 month period. In addition, MTT assay along with imaging techniques were used to evaluate the cell viability. Specifically, both direct MTT assay at intervals of 24 hours, 3 days and 7 days and indirect MTT assay in a 24 hour period were taken place.
Moreover, the cells were stained with methylene Blue dye and observed by optical microscopy. Afterwards, RGD peptides and laminins were immobilized on the surface of CA scaffolds in order to mimic the real exterior environment of the cells and promote cell proliferation. Finally, the biofunctionalized CA scaffolds were deposited on the surface of an aortic heart valve which was made of pyrolytic carbon for avoidance of heart valve thrombosis.
Materials and Methods

Materials
Acetone (99.9%, Sigma-Aldrich), Dimethylacetamide (DMAc 99.9%, Sigma-Aldrich) and vacuumed dried cellulose acetate (CA, Mn = 30,000, 39.8% acetyl groups, Sigma Aldrich). All solutions were used without further purification and all solutions were prepared by deionised water.
Methods
Scaffold Fabrication with Electrospray Deposition System
The nanofibrous CA scaffolds for cell growth were fabricated by electrospinning through the electrostatic spray deposition (ESD) method, (Esprayer ES-2000S, Fuence, Japan) onto aluminum foil and glass substrates. For fabrication of the polymeric solutions, two solutions of cellulose acetate were prepared with a total concentration of 16 wt% and 20 wt% in a solvent mixture of Acetone: DMA (2:1). The number of syringes were used for fabrication were 1 or 2. The solution was electrospun from a 5 mL syringe (or two syringes) with 24 or 21 gauge needles and mass flow rate of 10 -15 μL/min. A high voltage (25 kV) was applied to the tip of the needle when the fluid jet was ejected.
The distance between the needle and the moving collector in the XY stage, was set at 200 mm. The glass substrates were cleaned prior to electrospinning with isopropanol and methanol and blow-dried using N2 flow. Each fabricated film was left overnight to allow the evaporation of any residual solvents.
Physicochemical Characterization 1) Scanning electron microscopy (SEM)
The cells were fixed in 500 μl of 2.5% glutaraldehyde solution in PBS for 20 min at room temperature and dehydrated with a series of increasing concentration ethanol solutions (70%, 90% and 100% ethanol, 30 min in each). After ethanol dehydration, the morphological analysis of the PCL scaffolds was carried out by using SEM (NEON40, Carl Zeiss).
2) Atomic force microscopy (AFM)
Atomic force microscopy, AFM (AFM Solver, NT-MDT) was used to determine surface nanotopography and roughness of the cellulose acetate scaffolds. AFM is a very high-resolution type of scanning probe microscope, with demonstrated resolution of fractions of a nanometer, ideal for the imaging of biological samples due to its nondestructive performance. It can also provide size characterization in all three spatial dimensions, because it provides direct information about the height as well as lateral dimensions of the samples.
3) Contact angle measurements
Static contact angle measurements using water (Contact angle-surface tensionmeter CAM200, KSV Instruments Ltd) for the electrospun CA scaffolds were performed to study and compare the effect of the different CA fibers (CA concentration, needle size and number of syringes) on the surface hydrophilicity. At least six different measurements on the nanofibrous surfaces were obtained and the average values for contact angles were calculated. The maximum error in the contact angle measurement did not exceed ±3%.
4) Biodegradation study
We studied the degradation of cellulose acetate fibers in a period of 2 months (the time periods used are 3, 7, 14, 30, 45 and 60 days). The substrate of the samples was aluminium foil and they were cut into dimensions 10x10cm. Samples were weighed on a balance precision before and after degradation, and the results were recorded. Also samples were imaged with SEM and then treated with the Image J program in order to calculate the length of the fiber diameter. In each picture (magnification ×4000) were counted 25 different fibers.
Biological Characterization 1) Direct MTT assay
MTT assay (Sigma-Aldrich, Germany) was used to evaluate the cell viability. The cells used in this study were mouse fibroblasts L929 and were kindly offered from the Department of Biochemistry of the Aristotle University of Thessaloniki. The cell line was cultured in Medium 199 (Gibco, Life Technologies, Carlsbad, CA), containing 5% fetal bovine serum, ascorbic acid, and gentamicin at 37˚C, in a humidified atmosphere of 5% CO 2 in air. In a similar manner as described in [28] , the cell growth was stopped after 1 day, 3 days and 1 week. After each time point, the cells were incubated with a tenth of the medium of the bromide in 5% CO 2 (37˚C, 2 h) to allow the formation of water-insoluble formazan crystals. The optical densities (O.D.) of the solutions were read with a spectrophotometer, at the wavelength of 570 nm with respect to the reference wavelength of 690 nm. Data (n = 3) were presented as means of O.D. values as well as normalized according to the control and presented as% cell viability.
2) Indirect MTT assay
Additionally, an indirect MTT assay was taken place, on which the extracts of cellu-lose acetate nanoscaffolds hydrolyzed from the experiment of degradation (they were isolated from six time periods 3, 7, 14, 30, 45 and 60 days), deposited onto L929s cells and the toxicity was calculated based on optical density (O.D.) just described in direct MTT assay.
Cell Imaging
Once fibroblasts were seeded onto either unmodified or surface-modified nanofibrous scaffolds, cellular morphology and cell attachment were observed after 1, 3 and 7 days.
Cells were fixed, after the predetermined time periods, in 4% formaldehyde/PBS, at rt for 20 min, permeabilized with PBS and incubated with methylene blue (blue fluorescence) at rt for 30 min. The cell surface was observed with an optical microscope (Carl Zeiss, Germany).
Biofunctionalization Study 1) Biofunctionalization process
The surface treatment was used in cellulose acetate samples in order to bind mole- 2) CA scaffolds deposition on aortic metallic heart valve
The CA scaffold was deposited on the surface of aortic valve from pyrolytic carbon by ESD. Then, the samples were biofunctionalized by adding RGD peptide and laminins as described previously and then L929s cells were cultured on the surface of the valve for periods of 1 and 3 days. Lastly, the nanofiber based valve was imaged by SEM.
Results
Surface Nanotopography and Structural Properties of CA-Based Scaffolds
The CA nanofibrous scaffolds were prepared by electrospinning, using different system (Table 1) . AFM has been a widely used technique for the observation of biomaterials at the atomic scale. Thus, it was used in order to determine the topographical features and roughness of the engineered scaffolds. The surface roughness parameters of the electrospun CA scaffolds are summarized in Table 2 , while the obtained topographies of the samples are presented in Figures 1(g) -(l).
Wettability
Contact angle analysis provides information on the hydrophobicity or hydrophilicity of materials. Table 2 shows the values of water contact angle measurements of the CA surfaces. It was found that the sample 16% w/v produced by 1 syringe with 21G needle shows the maximum hydrophobicity and the sample 20% w/v produced by 1 syringe with 24G needle shows the maximum hydrophilicity. We also observed that the samples with 21G needle exhibit a higher hydrophobicity compared with corresponding samples (CA concentration and number of syringes) with 24G needle.
Biodegradability
CA-based scaffolds not only should have ideal morphological, structural and mechanical properties but also must present good rate of biodegradability in order to be suitable for a tissue engineering process. Scaffolds degradation comprises the hydrolysis and de-acetylization of the polymer. CA scaffolds were placed in cell's medium solution for 2 months. The experiment was divided into six periods (3, 7, 14, 30, 45 and 60 days) during which the scaffolds had been checked for their degradability. It was found that the samples with the largest cellulose acetate concentration, 20% w/v are heavier than the ones with 16% w/v, as you can observe in Figure 2 . When the 21G needle was used in electrospinning, in 14 days the samples the samples 16% w/v and 20% w/v had the highest weight and then during the rest of the study reduced weight due to their degradation. At 45 days observed for both concentrations, a slight increase in weight of the samples which then decreases (Figure 2(a) ). The sample 16% w/v produced by 2 syringes had less weight compared to the sample with the same concentration, but produced by one needle. On the other hand, in the case of the samples produced by 24G needle, it was observed that at 7 days the sample 16% w/v showed the highest weight and then during the rest of the study reduced weight due to their degradation. At 14 days the 20% w/v sample showed higher weight and then until the end of the study, it reduced weight due to degradation as well (Figure 2(b) ). The sample 16% w/v produced by 2 syringes, was found to have less weight compared to the sample with the same concentration, but produced by one needle. Also, the sample developed with 24G needle exhibited smaller diameter fibers compared to samples with 21G as presented in Furthermore, we studied the reduction of the diameter of the fibers in the six periods of the degradation study. More precisely, we calculated the diameter of 25 different fibers in ach SEM image, using image J software. The results are shown in Table 3 and Figure 4 . It was found that in all samples, as the days went on, the diameter of the CA fibers decreases during the time.
Cytotoxicity
The MTT results which derived from the cytotoxicity levels of all the samples in direct contact with the L929s are given in Figure 5 . According to the findings, all the fabricated scaffolds were found to be cytocompatible after a period of seven days and exhibited cell viability levels similar to those of the control group. Also, the sample with 20% w/v CA concentration, produced by the 24G needle and 1 syringe has shown the best cell viability levels. This effect is reinforced by the SEM images as well in Figure 6 .
Additionally, it was found that samples with 2 syringes do not show strong cell proliferation in comparison with the sample produced by 1 syringe. Cells, particularly at 3 and 7 days were exhibited protrusions begging from the cell body (lamellipodia) and extending to filopodia. These findings are indicative of cell migration, sensing and interaction with the biomaterial. 
Biofunctionalization
In biofunctionalization, the sample which was selected 20% w/v CA concentration, 
Aortic Valve Surface Coated with Biofunctionalized CA Scaffold
CA-based nanofibrous biofunctionalized scaffolds were deposited on the surface of the aortic heart valve leaflets made of pyrolytic carbon. From the SEM images it was found that cells were grown successfully on the valve surface ( Figure 10 ). Cells in 24 hours Figure 7 . Diagram of (OD) Optical density at 570 nm (cell viability%) after indirect MTT assay, using L929s cell line for at 24 h. Solvents:Acetone/DMAc, 2:1. 
Discussion
In this study, we demonstrated that CA-based nanoscaffolds, which are deposited onto aortic heart valve leaflets promote cell growth. This was achieved through the study of the factors that affect cell adhesion onto cellulose acetate scaffolds surface, such as physicochemical and morphological properties of the polymer as well as testing their biodegradability behavior. It is known that the CA-bas scaffolds improve their integrity by blending with other polymers like PBA [poly (buty acrylate)] [25] . Additionally, an optimized scaffold which are used in tissue regeneration should consist of a dense network of interlocking fibers with uniform size distribution and minimal or no presence at all of beads. So, it is known [22] [30] that solvent selection along with flow rate and CA concentration strongly influenced the cellulose acetate fiber size, size distribution, and fiber geometry. As regards the acetone/DMAc system, residual DMAc was retained within the electrospun mat. This retention helped to create physical crosslinks between fibers for the electrospun mats allowing the preservation of structure after the regenera-tion process. In this study we demonstrated how additional parameters such as, needle size, number of syringes and CA concentration can influence the CA fiber size, size distribution, and fiber geometry and therefore topography, roughness, wettability and biodegradability. We observed that (Table 1) as they show greater upheavals in their weight, and take longer to achieve a complete degradation ( Figure 2 ). In contrast, the hydrophilic samples showed lower rate of degradation. Also from the samples with 20% w/v CA, which are both hydrophilic, the scaffold with 24G degrades faster over 2 months in relation to the scaffold with 21G, as it exhibits a higher hydrophilicity (Figure 2(c) ). So far, in other studies, degradation of cellulose acetate fibers have achieved by using either the cellulase (cytocompatible enzyme) [16] or by using KOH/ethanol [31] for hydrolysis of fibers. The CA degradation produces acetyl groups and OH − . In this study, the deacetylation of CA fibers was carried out with the cell's medium. A reduce in fiber's diameter was observed as the days went on. In MTT direct assay, the time intervals 24 hours, 3 days and 7 days were se- 
Conclusion
In summary, we have successfully performed the development and characterization of the physicochemical and morphological properties of cellulose-acetate-based nanoscaffolds and the subsequent use of them as coverings onto aortic heart valve surface in order to attempt creation of an artificial valve that simulates the properties of a native valve. Bioactive factors, such as RGD peptides and laminins not only make the valve's surface more biocompatible but also could provide controlled endothyliazation and therefore a reduction in valve thrombosis. In this way, if we manage to combine the advantages of artificial valves with those of biological ones, it is almost sure that in the future we will have more efficient valves, which will not generate thrombosis after admission the patient's body and so the patient would not need anticoagulation for a lifetime. Although modest progress has been made toward the goal of a clinically useful tissue engineered heart valve, further success and ultimate human benefit will be dependent upon advances in biodegradable scaffolds, cellular manipulation and biofunctionalization strategies for rebuilding the native cardiac tissues.
